Literature DB >> 28208222

A case of aggressive solid pseudopapillary neoplasm: Comparison of clinical and pathologic features with non-aggressive cases.

Yukihiro Watanabe1, Kojun Okamoto1, Katsuya Okada1, Masayasu Aikawa1, Isamu Koyama1, Hiroshi Yamaguchi2,3.   

Abstract

Solid pseudopapillary neoplasms (SPNs) may have an aggressive clinical course, but clinical predictors of this condition have not been thoroughly evaluated. We performed a retrospective study of 11 cases of SPN managed in our hospital between January 2007 and April 2015. Of these 11 cases, we encountered a single case with an aggressive clinical course. Histological, immunohistochemical, and clinical features were compared to identify predictors of poor prognosis. The 11 patients comprised four women and seven men with a median age of 41 years (range, 26-58 years). Clinical symptoms were nonspecific and the median tumor size was 4.6 cm (range, 1.4-18 cm). The patient with an aggressive clinical course developed multiple liver metastases within three months and died seven months after surgery. Pathological features of the tumor in this case included lymph node metastases, a diffuse growth pattern, extensive tumor necrosis, high mitotic rate, and immunohistochemistry. These features were not observed in patients who survived without recurrence at a median follow-up of 25 months (range, 6-82 months). Characteristic pathological features and a high proliferative index, as assessed by Ki-67 staining, may predict poor outcome in cases of SPN.
© 2017 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  clinically aggressive solid pseudopapillary neoplasm; malignant transformation; pancreatic neoplasms

Mesh:

Substances:

Year:  2017        PMID: 28208222     DOI: 10.1111/pin.12516

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  8 in total

1.  Solid Pseudopapillary Neoplasm of the Pancreas: Clinicopathologic Feature, Risk Factors of Malignancy, and Survival Analysis of 53 Cases from a Single Center.

Authors:  He Song; Ming Dong; Jianping Zhou; Weiwei Sheng; Banghua Zhong; Wei Gao
Journal:  Biomed Res Int       Date:  2017-09-28       Impact factor: 3.411

2.  Aggressiveness of solid pseudopapillary neoplasm of the pancreas: A literature review and meta-analysis.

Authors:  Emmanuel Ii Uy Hao; Ho Kyung Hwang; Dong-Sub Yoon; Woo Jung Lee; Chang Moo Kang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

3.  Surgical approach to solid pseudopapillary neoplasms of the proximal pancreas: minimally invasive vs. open.

Authors:  Emmanuel Ii Uy Hao; Seoung Yoon Rho; Ho Kyoung Hwang; Jae Uk Chung; Woo Jung Lee; Dong Sup Yoon; Chang Moo Kang
Journal:  World J Surg Oncol       Date:  2019-09-12       Impact factor: 2.754

4.  Clinical Pattern of Preoperative Positron Emission Tomography/Computed Tomography (PET/CT) Can Predict the Aggressive Behavior of Resected Solid Pseudopapillary Neoplasm of the Pancreas.

Authors:  Ji-Su Kim; Emmanuel Ii-Uy Hao; Seoung-Yoon Rho; Ho-Kyoung Hwang; Woo-Jung Lee; Dong-Sub Yoon; Chang-Moo Kang
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

5.  Repeated Resection for Recurrent Metastatic Solid Pseudopapillary Neoplasm of the Pancreas.

Authors:  Kentaro Ichimura; Takahiro Uesaka; Hironobu Kikuchi; Koji Okuda; Masao Sunahara; Takahiro Oshima; Kazuhito Misawa
Journal:  Am J Case Rep       Date:  2021-12-21

6.  Current highlights on solid pseudopapillary neoplasm of the pancreas.

Authors:  Simone Sibio; Sara Di Carlo
Journal:  World J Hepatol       Date:  2022-01-27

7.  Solid Pseudopapillary Neoplasm of the Uncinate Process of the Pancreas: A Case Report and Review of the Literature.

Authors:  Muhammad Rafay Khan Niazi; Samyak Dhruv; Abhishek Polavarapu; Mesut Toprak; Indraneil Mukherjee
Journal:  Cureus       Date:  2021-05-19

8.  Solid Pseudopapillary Neoplasm of the Pancreas with High-Grade Malignant Transformation Involving p16-RB Pathway Alterations.

Authors:  Kodai Tomioka; Nobuyuki Ohike; Takeshi Aoki; Yuta Enami; Akira Fujimori; Tomotake Koizumi; Tomokazu Kusano; Koji Nogaki; Yoshihiko Tashiro; Yusuke Wada; Tomoki Hakozaki; Hideki Shibata; Takahito Hirai; Tatsuya Yamazaki; Koichiro Fujimasa; Tomoko Norose; Tomohide Isobe; Masahiko Murakami
Journal:  Case Rep Surg       Date:  2020-01-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.